Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

[1]  J. Riba,et al.  Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study , 2016, Journal of clinical psychopharmacology.

[2]  F. Vollenweider,et al.  Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers , 2015, Biological Psychiatry.

[3]  J. Riba,et al.  Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study. , 2015, Drug testing and analysis.

[4]  A. Frood.  Ayahuasca psychedelic tested for depression , 2015, Nature.

[5]  S. Ribeiro,et al.  Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans , 2015, European Neuropsychopharmacology.

[6]  Amber L. Calloway,et al.  Decentering as a potential common mechanism across two therapies for generalized anxiety disorder. , 2015, Journal of consulting and clinical psychology.

[7]  R. Baños,et al.  Assessing decentering: validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample. , 2014, Behavior therapy.

[8]  V. Pérez,et al.  Psychometric properties of the Spanish version of the Philadelphia Mindfulness Scale. , 2014 .

[9]  T. Passie,et al.  Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases , 2014, The Journal of nervous and mental disease.

[10]  Susan Bliss,et al.  An Exploration of Common Elements in Dialectical Behavior Therapy, Mentalization Based Treatment and Transference Focused Psychotherapy in the Treatment of Borderline Personality Disorder , 2014 .

[11]  Rosa Baños,et al.  Relationship between Meditative Practice and Self-Reported Mindfulness: The MINDSENS Composite Index , 2014, PloS one.

[12]  L. Lundh,et al.  Observing as an Essential Facet of Mindfulness: A Comparison of FFMQ Patterns in Meditating and Non-Meditating Individuals , 2013 .

[13]  J. Riba,et al.  Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study , 2012, PloS one.

[14]  R. Baños,et al.  Psychometric properties of the Spanish validation of the Five Facets of Mindfulness Questionnaire (FFMQ) , 2012 .

[15]  P. Grossman.  Defining mindfulness by how poorly I think I pay attention during everyday awareness and other intractable problems for psychology's (re)invention of mindfulness: comment on Brown et al. (2011). , 2011, Psychological assessment.

[16]  Britta K. Hölzel,et al.  How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective , 2011, Perspectives on psychological science : a journal of the Association for Psychological Science.

[17]  E. Taal,et al.  Psychometric properties of the Dutch Five Facet Mindfulness Questionnaire (FFMQ) in patients with fibromyalgia , 2011, Clinical Rheumatology.

[18]  C. Grob,et al.  Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. , 2011, Archives of general psychiatry.

[19]  B. Fredrickson,et al.  Deconstructing Mindfulness and Constructing Mental Health: Understanding Mindfulness and its Mechanisms of Action , 2010 .

[20]  J. Riba,et al.  Assessment of addiction severity among ritual users of ayahuasca. , 2010, Drug and alcohol dependence.

[21]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[22]  M. Mintun,et al.  Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus , 2010, Proceedings of the National Academy of Sciences.

[23]  L. Standish,et al.  Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2009, Journal of chromatography. A.

[24]  J. Carmody,et al.  An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program. , 2009, Journal of clinical psychology.

[25]  M. Jackson,et al.  The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.

[26]  Kenneth W. Tupper.  The globalization of ayahuasca: harm reduction or benefit maximization? , 2008, The International journal on drug policy.

[27]  P. Grossman.  On measuring mindfulness in psychosomatic and psychological research. , 2008, Journal of psychosomatic research.

[28]  Michael T. Moore,et al.  Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decentering. , 2007, Behavior therapy.

[29]  J. Landeira-Fernández,et al.  Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. , 2007, Journal of ethnopharmacology.

[30]  Z. Segal,et al.  Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. , 2007, Journal of consulting and clinical psychology.

[31]  Z. Segal,et al.  Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. , 2006, Archives of general psychiatry.

[32]  S. Romero,et al.  Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant , 2006, Psychopharmacology.

[33]  Gregory T. Smith,et al.  Using Self-Report Assessment Methods to Explore Facets of Mindfulness , 2006, Assessment.

[34]  J. Astin,et al.  Mechanisms of mindfulness. , 2006, Journal of clinical psychology.

[35]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[36]  J. Serrano.  Human pharmacology of ayahuasca , 2003 .

[37]  J. Riba,et al.  Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics , 2003, Journal of Pharmacology and Experimental Therapeutics.

[38]  B. Shanon.  The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience , 2003 .

[39]  Richard G. Moore,et al.  Metacognitive awareness and prevention of relapse in depression: empirical evidence. , 2002, Journal of consulting and clinical psychology.

[40]  G. Shulman,et al.  Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Edna B. Foa,et al.  The impact of fear activation and anger on the efficacy of exposure treatment for posttraumatic stress disorder. , 1995 .

[42]  D. Mckenna,et al.  Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. , 1984, Journal of ethnopharmacology.

[43]  Y. Katsumata,et al.  Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase. , 1981, Biochemical pharmacology.

[44]  K. Suzuki,et al.  Essential metals and metallothionein in cadmium-induced thymic atrophy and splenomegaly. , 1981, Biochemical pharmacology.

[45]  Trevor Silverstone.  Psychopharmacology , 1979, British Journal of Psychiatry.

[46]  N. Buckholtz,et al.  Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity. , 1977, Biochemical pharmacology.

[47]  N. Buckholtz,et al.  Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationships , 1977 .

[48]  J. Lindgren,et al.  “Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation , 1972, Economic Botany.

[49]  Matthew W. Johnson,et al.  Can psychedelic compounds play a part in drug dependence therapy? , 2015, The British journal of psychiatry : the journal of mental science.

[50]  D. Araujo,et al.  Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. , 2015, Revista brasileira de psiquiatria.

[51]  Habib Benali,et al.  Impact of meditation training on the default mode network during a restful state. , 2013, Social cognitive and affective neuroscience.

[52]  Z. Segal,et al.  Mindfulness: A Proposed Operational Definition , 2004 .

[53]  R. Ryan,et al.  The benefits of being present: mindfulness and its role in psychological well-being. , 2003, Journal of personality and social psychology.

[54]  A. Rodríguez-Fornells,et al.  Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers , 2000, Psychopharmacology.

[55]  J. Kabat-Zinn,et al.  Full catastrophe living : using the wisdom of your body and mind to face stress, pain, and illness , 1990 .

[56]  N. Buckholtz,et al.  Inhibition by beta-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships. , 1977, Life sciences.

[57]  R. Schultes,et al.  The Botany and Chemistry of Hallucinogens , 1974 .

[58]  G. Martin,et al.  Send Orders of Reprints at Reprints@benthamscience.net Ayahuasca-assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada , 2022 .